AIM: To investigate the treatment strategies and long-term outcomes of radiofrequency
ablation (RFA) of hepatocellular carcinoma (HCC) in difficult locations and to compare the …

AIM: To investigate whether an ablative margin (AM)> 1.0 cm might reduce chance of
recurrence for patients with hepatocellular carcinoma (HCC) tumors 3.1 to 5.0 cm in size …

AIM: To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular
carcinoma (HCC) and identify survival-and recurrence-related factors. METHODS …

Results The 5-year OS rate of the entire sample was 44.3%(95% confidence interval: 36.7–
55.8); Child–Pugh class B was the worst negative prognostic factor (hazard ratio: 2.06; P …

We evaluated the efficacy and safety of radiofrequency (RF) ablation for hepatocellular
carcinoma (HCC) in presumably high‐risk locations. Between February 1999 and December …

Hypothesis Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) can be
performed by percutaneous or surgical approach. Tumor size is an important consideration …

Purpose To compare retrospectively the effects of percutaneous radiofrequency (RF)
ablation with those of hepatic resection in the treatment of hepatocellular carcinoma (HCC) …

Background Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is ordinarily
indicated for those with three or fewer nodules, none of which exceeds 3 cm in diameter …

Objective: The purpose of this study was to evaluate the risk factors for local recurrence with
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) measuring≤ 2 cm …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …